Biocon Ltd. NSE: BIOCON | BSE: 532523

Slowing Down Stock

316.55 10.25 (3.35%)

3.3M NSE+BSE Volume

NSE 11 Apr, 2025 3:31 PM (IST)

US FDA Approval

Biocon receives USFDA approval for Jobevne, used in cancer treatment, with a market size of ~$2 bn See details

Detailed Stock Analysis for Biocon Ltd. with Real-time Stock Report